2 results
Approved WMOPending
To study the impact on intra-arterial ATP infusion on Annexin A5 targeting.
Approved WMOCompleted
The primary objectives of the Phase Ib portion of the study are as follows:* To assess the safety and tolerability of the combination of polatuzumab vedotin with bendamustine and rituximab (BR) or bendamustine and obinutuzumab (BG) when administered…